OUR FOCUS ON INNOVATIVE MEDICINE
We have developed expertise through our comprehensive study of industry and academic efforts in targeted areas of significant innovation. By focusing our energies, we believe we can add more value to entrepreneurs and scientists. Our current focus areas include both technology platforms and disease areas.
What's New At RTW
Health Sciences Acquisitions Corporation 2 Announces Closing of Upsized $160 Million Initial Public Offering, Including Full Exercise of the Underwriters’ Over-Allotment Option
Health Sciences Acquisitions Corporation 2 (Nasdaq: HSAQ, the "Company" or "HSAC 2") announced today that it closed its initial public offering of 16,000,000 ordinary shares, which included the full exercise of the underwriters' over-allotment option.
RTW Investments, LP, Ji Xing Pharmaceuticals and Cytokinetics Enter Into Strategic Financing Collaboration to Support the Development of CK-274 and Enter China
RTW Investments, a global, full life-cycle investor provides a multi-faceted capital solution to support Cytokinetics’ development of CK-274; including direct equity investment, royalty monetization, and royalty-backed development funding.
This Disability Rights Activist Wants to Be the First Wheelchair User in Space
There can be irony in even the happiest of sentiments—a fact that is surely not lost on Eddie Ndopu. The son of a South African mother and a Namibian father, Ndopu was born in 1990, the year Namibia attained its independence from South Africa, and just four years before Nelson Mandela became South Africa’s first black President.
We support companies through the ups and downs of the often challenging journey to bring therapies to patients.
The Future Looks Bright
Gene sequencing has identified causes for over 4,000 diseases, and is growing at a rate of 200 per year.
Drugs in the Pipeline
Lives Saved Each Year
Identify unmet needs
We try to ignore the crowd and prioritize where we think unmet needs can be solved by mature science.
Invest in relationships
We believe in developing longterm relationships with great entrepreneurs and scientists who are as passionate about medicine as we are.